Pap Smears in HIV-Infected Women

2000 ◽  
Vol 9 (1) ◽  
pp. 45-45
Keyword(s):  
Pap Smears

The Prevalence of HR-HPV DNA in ASC-US Pap Smears

2006 ◽  
Vol 10 (4) ◽  
pp. 274
Author(s):  
MP Stany ◽  
MA Bidus ◽  
EJ Reed ◽  
KJ Kaplan ◽  
MT McHale ◽  
...  
Keyword(s):  
Pap Smears ◽  
Hpv Dna

scholarly journals Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve

2021 ◽  
Vol 17 ◽  
pp. 174550652110170
Author(s):  
Hannah Masson
Keyword(s):  
Human Papilloma Virus ◽  
Cervical Screening ◽  
High Sensitivity ◽  
Health Board ◽  
Pap Smears ◽  
Local Health ◽  
Papilloma Virus ◽  
Face To Face ◽  
Screening Uptake ◽  
The Impact

Background: The Coronavirus disease 2019 (COVID-19) pandemic has led to an unprecedented upheaval within global healthcare systems and resulted in the temporary pausing of the National Health Service (NHS) Scotland Cervical Screening Programme. With several months of backlogs in appointments, there has not only been a reduction in primary samples being taken for human papilloma virus (HPV) testing but there have also been fewer women referred to colposcopy for investigation and treatment of precancerous or cancerous changes as a result. Encouraging uptake for cervical screening was always a priority before the pandemic, but it is even more important now, considering that the fears and barriers to screening that women may have are now exacerbated by COVID-19. Objectives: This article explores the impact of the pandemic on the uptake of cervical screening within NHS Ayrshire & Arran and evaluates potential strategies to improve uptake now and in future such as self-sampling and telemedicine. Methods: This article presents evidence-based literature and local health board data relating to cervical screening during the pandemic. Results: Human papilloma virus self-sampling carried out by the woman in her home has been shown to improve uptake, especially in non-attenders, whilst maintaining a high sensitivity and, crucially, reducing the need for face-to-face contact. Increased education is key to overcoming barriers women have to screening and telemedicine can strengthen engagement with women during this time. Conclusion: There are lessons to be learned from the pandemic, and we must use this opportunity to improve cervical screening uptake for the future.

scholarly journals HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study

Vaccines ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 643
Author(s):  
Rosa De Vincenzo ◽  
Nicola Caporale ◽  
Valentina Bertoldo ◽  
Caterina Ricci ◽  
Maria Teresa Evangelista ◽  
...  
Keyword(s):  
Pap Smear ◽  
Cox Regression ◽  
Vaccine Dose ◽  
Pap Smears ◽  
Adult Women ◽  
Sexually Active ◽  
Time Intervals ◽  
Dose Administration ◽  
Before And After ◽  
Single Cohort

Background: This study evaluates the possible effect of 9-valent (9vHPV) vaccination on the results of HPV and cytological tests in a cohort of adult women. Methods: This study is a retrospective, single-cohort, monocentric study. Sexually active women aged 14–70 years, who underwent 9vHPV vaccination, were enrolled. Dose administration dates, side effects and data on Pap smears and HPV tests performed before and after the first vaccine dose were collected. Subjects were considered “unexposed” to the vaccine for all time intervals before the first dose administration, and “exposed” to the first, second and third vaccine doses in all time intervals following each specific dose. Results: A total of 512 women underwent the first 9vHPV dose administration and were enrolled in the study. Median age at vaccination was 30.5 (14–70). Log-rank tests and Cox regression analyses showed a highly statistically significant (p < 0.0001) difference in the time to negativization after the exposure to the third vaccine dose in the 207 women starting with a Pap+ smear (HR (95% C.I.), 2.66 (1.83–3.86)) and in the 198 women starting with an HPV HR+ test (HR (95% C.I.), 7.80 (4.83–12.60)). Conclusions: 9vHPV vaccination may play a role in shortening the clearance time of HPV HR+ or Pap positivity in sexually active adult women.

scholarly journals Prevalence of abnormal PAP smears in antenatal women in a tertiary hospital in India

2016 ◽  
Author(s):  
Saritha Shamsunder ◽  
Akriti Gautam ◽  
Geetika Khanna ◽  
Sunita Malik
Keyword(s):  
Pregnant Women ◽  
Pap Smear ◽  
Cervical Screening ◽  
Developed Countries ◽  
Antenatal Clinic ◽  
Comfort Level ◽  
Good Time ◽  
Pap Smears ◽  
Minor Bleeding ◽  
The Mean

Background: Pregnancy provides a good time for opportunistic screening of our women who rarely attend for cervical screening. The prevalence of abnormal PAP smear in pregnant women in developed countries was 5-6%, however, no literature was available from India. Aim: To determine the prevalence of abnormal PAP smears in antenatal women presenting to our antenatal clinic. Methods: Women attending the antenatal clinic with gestation of <28 weeks were recruited after an informed consent and had a PAP smear by Ayre spatula and cytobrush or a broom type of cytobrush. The comfort level during smear taking & any problems noted were recorded using a pain score. The smears were stained using the PAP stain, were categorized as adequate or inadequate & classified as per Bethesda classification. Results: We had 150 women participating, the mean age was 24.2 yrs, the mean period of gestation was 17 weeks; 43.9% were nulliparous. Smear adequacy rate was 71.5% overall. Pain during procedure was reported in 2.9% of women, 18.3% had minor discomfort; 78.6% were comfortable. Minor bleeding during smear taking was noted in 15%; this was more with the cytobrush & broom than the Ayre spatula alone. Abnormal smears were seen in three women; two had AGC & one had LSIL. Conclusions: Opportunistic cervical screening during pregnancy is safe and well tolerated. Abnormal Cervical smears were seen in 2% of our pregnant women.

Sign in / Sign up

Export Citation Format

Share Document